Delta Point Continues to Expand Management Capabilities with Addition of Pharmaceutical Industry Leader Cathy Geddes PR Newswire MALVERN, Pa., April 3, 2013 MALVERN, Pa., April 3, 2013 /PRNewswire/ --Cathy Geddes, former commercial leader at Pfizer, Wyeth and Roche, has recently joined Delta Point, Inc. as Senior Vice President with responsibility for leading the operations of the business and developing innovative new marketing offerings. "Over the last few months Delta Point has brought in key talent who will enhance the company. In addition to Michael Hickey who recently joined as Senior Vice President of Global Leadership Development, Cathy has joined DPI to lead our efforts in improving internal organization processes and infrastructure which will allow us to continue to grow and fulfill our vision of being the premier specialty consulting firm in the life science space. As we've experienced significant growth over the last few years, it's the appropriate time to create a role committed to leading Operations," explained Jerry Acuff, founder and CEO of Delta Point. "Cathy's background and experience is also ideal for evolving our Marketing products to assist clients in optimizing brand performance," said Acuff. Geddes has a deep understanding of the pharmaceutical business having worked in the industry for over 20 years as a leader in marketing, sales, and account management in start-up, mid-size and large pharmaceutical organizations. She began her healthcare career in Marketing at start-up biotechnology company where she led the launch of an oncology product. She then spent 12 years at Roche Laboratories in various roles including Division Sales Manager, Regional Account Manager, National Account Manager, Regional Sales Director and several years leading the hepatology specialty sales force as National Sales Director. While at Roche she earned numerous awards, successfully launched eight products and gained experience promoting retail, hospital, and specialty products across 14 therapeutic areas. Geddes joined Wyeth in 2007 when she was recruited to lead the vaccine specialty sales team for several years as Vice President of Sales. After the Pfizer acquisition of Wyeth, she was asked to lead the Marketing team in the launch of Prevnar 13, a "buy & bill" specialty care pneumococcal vaccine, which under her leadership became the #1 product in first year sales in pharmaceutical history with over $2B in US revenue. She has a B.A. from Temple University and a M.B.A. from St. Joseph's University. About Delta Point, Inc. Headquartered in Scottsdale, AZ with a regional office in Malvern, PA, Delta Point, Inc. specializes in the life sciences industry (pharmaceutical, biotech, and device companies) by partnering with clients to maximize brand sales performance. Their focus is on improving outcomes by analyzing the needs of their customers before developing customized recommendations that align cross-functional departments: Sales, Marketing, Sales Training and Commercial Operations. Delta Point specializes in making those changes that help corporations deal with the challenges they face whether it is launching a new product or an underperforming brand by working with their clients as a partner in attaining business success. They have gained recognition for developing strategic sales and marketing plans, improving sales messaging, and for the effectiveness of their training programs, including a copyrighted process of building, sustaining and growing substantive business relationships. Contact: Jerry Acuff, CEO Delta Point, Inc. 480-296-9972 This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com. SOURCE Delta Point, Inc.
Delta Point Continues to Expand Management Capabilities with Addition of Pharmaceutical Industry Leader Cathy Geddes